# surgical.ai

> surgical.ai is a VC fund in Boston backing Medical and Software. See 4 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Boston, United States
- Total investments: 4
- Last investment: Aug 2024
- Lead investor: 25%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/surgical-ai/
- Website: http://www.surgical.ai

surgical.ai is a VC fund in Boston focused on Medical and Software. Surgical Intelligence is a hands-on company builder that provides investment and guidance for innovative technologies helping to bridge the artificial intelligence gap in healthcare. By focusing on technologies designed to impact surgery – the most mission-critical segment of the hospital – they are working to solve healthcare’s problems of highestacuity.

## Contacts

5 contacts available for surgical.ai. Shizune tracks 3 team members at surgical.ai. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/surgical-ai?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 25% |
| Software | 1 | 25% |
| Analytics | 1 | 25% |
| Health Care | 1 | 25% |
| Data Visualization | 1 | 25% |

6 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 25% |
| Series C | 1 | 25% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Alexander Kis | Vice President | 0 | — |
| Björn von Siemens | Co-Founder and Managing Partner | 6 | https://shizune.co/investors/profile/bjoern-von-siemens |
| Dennis Kogan | Co-Founder and Managing Partner | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Caresyntax | Caresyntax is a digital surgery platform that enables OR teams to predict and improve surgical performance. Its enterprise-grade digital surgery platform delivers insights to improve patient outcomes by using proprietary software and AI to analyze large volumes of video, audio, images, device data, clinical, and operational data in and around theOR.Caresyntax insights help surgeons benchmark and improve their care, hospital administrators use surgical resources more efficiently, medical device companies advance better products, and insurance companies understand risk and devise more tailored policies. The software is used in more than 4,000 operating rooms worldwide, has supported more than 30,000 surgeons, and improved care for more than 2 million patients. | $80M | Series C | Aug 15, 2024 |  |
| Caresyntax | Caresyntax is a digital surgery platform that enables OR teams to predict and improve surgical performance. Its enterprise-grade digital surgery platform delivers insights to improve patient outcomes by using proprietary software and AI to analyze large volumes of video, audio, images, device data, clinical, and operational data in and around theOR.Caresyntax insights help surgeons benchmark and improve their care, hospital administrators use surgical resources more efficiently, medical device companies advance better products, and insurance companies understand risk and devise more tailored policies. The software is used in more than 4,000 operating rooms worldwide, has supported more than 30,000 surgeons, and improved care for more than 2 million patients. | $130M | Series C | Sep 16, 2021 |  |
| Caresyntax | Caresyntax is a digital surgery platform that enables OR teams to predict and improve surgical performance. Its enterprise-grade digital surgery platform delivers insights to improve patient outcomes by using proprietary software and AI to analyze large volumes of video, audio, images, device data, clinical, and operational data in and around theOR.Caresyntax insights help surgeons benchmark and improve their care, hospital administrators use surgical resources more efficiently, medical device companies advance better products, and insurance companies understand risk and devise more tailored policies. The software is used in more than 4,000 operating rooms worldwide, has supported more than 30,000 surgeons, and improved care for more than 2 million patients. | $100M | Series C | Apr 28, 2021 |  |
| Caresyntax | Caresyntax is a digital surgery platform that enables OR teams to predict and improve surgical performance. Its enterprise-grade digital surgery platform delivers insights to improve patient outcomes by using proprietary software and AI to analyze large volumes of video, audio, images, device data, clinical, and operational data in and around theOR.Caresyntax insights help surgeons benchmark and improve their care, hospital administrators use surgical resources more efficiently, medical device companies advance better products, and insurance companies understand risk and devise more tailored policies. The software is used in more than 4,000 operating rooms worldwide, has supported more than 30,000 surgeons, and improved care for more than 2 million patients. | $20M | Series A |  |  |

4 of 4 investments shown.

## Co-investors
- [Intel Capital](https://shizune.co/investors/profile/intel-capital) — VC Fund, 3 deals together
- [Optum Ventures](https://shizune.co/investors/profile/optum-ventures) — VC Fund, 3 deals together
- [Relyens](https://shizune.co/investors/profile/relyens) — VC Fund, 3 deals together
- [Vesalius Biocapital Partners](https://shizune.co/investors/profile/vesalius-biocapital-partners) — VC Fund, 3 deals together
- [PFM Health Sciences](https://shizune.co/investors/profile/pfm-health-sciences) — VC Fund, 2 deals together
- ProAssurance — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does surgical.ai invest in?

surgical.ai invests primarily in Medical, Software and Analytics startups, most often at Series A and Series C stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact surgical.ai?

Public channels for surgical.ai include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at surgical.ai?

The team at surgical.ai includes Alexander Kis (Vice President), Björn von Siemens (Co-Founder and Managing Partner) and Dennis Kogan (Co-Founder and Managing Partner). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co